Study suggests hypercalcemia relapse is rare after dog parathyroidectomy
Persistent and recurrent hypercalcemia appear to be rare after parathyroidectomy for dogs with primary hyperparathyroidism, according to a new retrospective review in the American Journal of Veterinary Research. The study looked at cases from three academic veterinary hospitals between 2012 and 2022 and focused on dogs that underwent surgical removal of autonomously functioning parathyroid tissue. The authors set out to clarify how often postoperative hypercalcemia truly persists or returns, and how those outcomes should be defined, in a condition where surgery is generally considered definitive treatment. Broader veterinary references and earlier case series have long described recurrence as uncommon, while emphasizing that postoperative hypocalcemia is the more familiar short-term complication after surgery. (merckvetmanual.com)
Why it matters: For veterinary professionals, the paper helps sharpen expectations during case follow-up and client communication. In canine primary hyperparathyroidism, the bigger immediate management issue is often transient hypocalcemia after gland removal, not ongoing hypercalcemia. Earlier JAVMA and PubMed-indexed studies have shown postoperative hypocalcemia is common enough to warrant close calcium monitoring, while historical reports suggest persistent or recurrent hypercalcemia may be linked to multigland disease, hyperplasia, missed abnormal tissue, or, more rarely, ectopic or metastatic disease. That makes clearer definitions of “persistent” versus “recurrent” hypercalcemia clinically useful when deciding whether a dog needs routine monitoring, additional imaging, medical management, or referral for reintervention. (pubmed.ncbi.nlm.nih.gov)
What to watch: Watch for the full AJVR publication details and any institution-level commentary that adds the study’s exact case counts, recurrence timing, and identified causes of failure, because those specifics will shape how surgeons and internists benchmark outcomes and plan surveillance. (pubmed.ncbi.nlm.nih.gov)